Shandong Buchang Pharmaceuticals Co Ltd Class A 603858
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 36.15
- Price/Sales
- 1.59
- Dividend Yield (Trailing)
- 0.75%
- Dividend Yield (Forward)
- 0.75%
- Total Yield
- 0.75%
Company Profile
Shandong Buchang Pharmaceuticals Co Ltd is engaged in research and development, production and sales of Chinese patent medicines.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 8,311
- Website
- https://www.buchang.com
Comparables
Valuation
|
Metric
|
603858
|
000919
|
600211
|
|---|---|---|---|
Price/Earnings (Normalized) | 36.15 | 58.45 | 12.42 |
Price/Book Value | 1.65 | 1.07 | 3.13 |
Price/Sales | 1.59 | 1.20 | 4.06 |
Price/Cash Flow | 17.05 | 15.61 | 9.42 |
Price/Earnings
603858
000919
600211
Financial Strength
|
Metric
|
603858
|
000919
|
600211
|
|---|---|---|---|
Quick Ratio | 0.48 | 3.28 | 2.65 |
Current Ratio | 1.28 | 3.61 | 2.80 |
Interest Coverage | 0.41 | 388.44 | 72.67 |
Quick Ratio
603858
000919
600211
Profitability
|
Metric
|
603858
|
000919
|
600211
|
|---|---|---|---|
Return on Assets (Normalized) | −0.45% | 1.25% | 14.77% |
Return on Equity (Normalized) | −0.83% | 1.83% | 20.58% |
Return on Invested Capital (Normalized) | −0.07% | 1.04% | 16.12% |
Return on Assets
603858
000919
600211
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Vfykbvnjws | Hnb | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Vzzlvptt | Pvpqx | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Qqwbwstnr | Ytj | $48.4 Bil | |||
| Viatris Inc
VTRS
| Gbycygb | Mxnht | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Nsvpdwk | Lwxzw | $13.5 Bil | |||
| Catalent Inc
CTLT
| Thzlspdn | Mvfsqpn | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Yytfycnk | Vklmmyz | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Pfypqpsw | Zdlp | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Fyhmlfxrth | Ssbt | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Dvbgnnxv | Hlp | $2.3 Bil |
United States